[1] Lannert H, Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats [J]. Behav Neurosci, 1998, 112(5): 1199-208. [2] Hoyer S. Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update [J]. Exp Gerontol, 2000, 35(9-10): 1363-72. [3] Greenfield JP, Tsai J, Gouras GK, et al. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimerbeta-amyloid peptides [J]. Proc Natl Acad Sci USA, 1999, 96(2): 742-7. [4] Blokland A, Jolles J. Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin [J]. Pharmacol Biochem Behav, 1993, 44(2): 491-4. [5] Gouras GK, Tsai J, Naslund J, et al. Intraneuronal Abeta42 accumulation in human brain [J]. Am J Pathol, 2000, 156(1 ): 15-20. [6] Sharma M, Gupta YK. Intracerebroventricular injection of strepto zotocin in rats produces both oxidative stress in the brain and cognitive impairment[J]. Life Sci, 2001, 68(9): 1021-9. [7] 包新民,舒斯云.大鼠脑立体定向图谱[M].北京:人民卫生出版社.1991.12-8. [8] 申洪.免疫组织化学定量方法研究[J].中国组织化学与细胞化学杂志,1995,4(1):89-91.Sheng H. Study on the quantitative method of immunohistochemistry[J]. Chin J Histochem Cytochem, 1995, 4(1): 89-91. [9] Hoyer S. Glucose metabolism and insulin receptor signal transduction in Alzheimer disease[J]. Eur J Pharmacol, 2004, 490(1-3): 115-25. [10] Shoham S, Bejar C, Kovalev E, et al. Intracerebroventricular inje ction of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats[J]. Exp Neurol, 2003,184(2): 1043-52. [11] Merkel P, Khoury N, Bertolotto C, et al. Insulin and glucose regulate the expression of the DNA repair enzyme XPD [J]. Mol Cell Endocrinol, 2003, 201(1-2): 75-85. [12] Zhao W, Chen H, Xu H, et al. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats[J]. J Biol Chem, 1999, 274(49): 34893-902. [13] Haass C, Koo EH, Mellon A, et al. Targeting of cell-surface betaamyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments [J]. Nature, 1992, 357(6378): 500-3. [14] Mochizuki A, Tamaoka A, Shimohata A, et al. Abeta42-positive non-pyramidal neurons around amyloid plaques in Alzheimer’s disease [J]. Lancet, 2000, 355(9197): 42-3. [15] Hartmann T. Intracellular biology of Alzheimer’s disease amyloid beta peptide [J]. Eur Arch Psychiatry Clin Neurosci, 1999, 249(6):291-8. [16] Yang AJ, Chandswangbhuvana D, Shu T, et al. Intracellular accumulation of insoluble, newly synthesized abetan-42 in amyloid precursor protein-transfected cells that have been treated with Abetal-42 [J]. J Biol Chem, 1999, 274(29): 20650-6. [17] Morishima-Kawashima M, Hasegawa M, Takio K, et al. Hyperphosphorylation of tau in PHF [J]. Neurobiol Aging, 1995, 16(3): 365-71 [18] Takahashi M, Tomizawa K, Ishiguro K. Distribution of tau protein kinase I/glycogen synthase kinase-3beta, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain [J]. Brain Res, 2000, 857(1-2): 193-206. |